| Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression A Melcher, S Todryk, N Hardwick, M Ford, M Jacobson, RG Vile Nature medicine 4 (5), 581-587, 1998 | 568 | 1998 |
| Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ … AG Jarnicki, J Lysaght, S Todryk, KHG Mills The journal of immunology 177 (2), 896-904, 2006 | 536 | 2006 |
| The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells C Galustian, B Meyer, MC Labarthe, K Dredge, D Klaschka, J Henry, ... Cancer Immunology, Immunotherapy 58, 1033-1045, 2009 | 466 | 2009 |
| Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake S Todryk, AA Melcher, N Hardwick, E Linardakis, A Bateman, ... The Journal of Immunology 163 (3), 1398-1408, 1999 | 463 | 1999 |
| Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ... Journal of Infectious Diseases 205 (5), 772-781, 2012 | 252 | 2012 |
| Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15 J Dunne, S Lynch, C O’Farrelly, S Todryk, JE Hegarty, C Feighery, ... The Journal of Immunology 167 (6), 3129-3138, 2001 | 222 | 2001 |
| Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity K Dredge, JB Marriott, SM Todryk, GW Muller, R Chen, DI Stirling, ... The Journal of Immunology 168 (10), 4914-4919, 2002 | 213 | 2002 |
| A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya P Bejon, J Mwacharo, O Kai, T Mwangi, P Milligan, S Todryk, S Keating, ... PLoS clinical trials 1 (6), e29, 2006 | 183 | 2006 |
| Facets of heat shock protein 70 show immunotherapeutic potential SM Todryk, MJ Gough, AG Pockley Immunology 110 (1), 1-9, 2003 | 182 | 2003 |
| Immunotherapeutic potential of whole tumour cells S Ward, D Casey, MC Labarthe, M Whelan, A Dalgleish, H Pandha, ... Cancer Immunology, Immunotherapy 51, 351-357, 2002 | 174 | 2002 |
| Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen‐specific Th1 and enhancement of Th2 … P Byrne, P McGuirk, S Todryk, KHG Mills European journal of immunology 34 (9), 2579-2588, 2004 | 172 | 2004 |
| Apoptosis or necrosis for tumor immunotherapy: what's in a name? A Melcher, M Gough, S Todryk, R Vile Journal of molecular medicine 77, 824-833, 1999 | 172 | 1999 |
| Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy K Dredge, BJ Marriott, SM Todryk, AG Dalgleish Cancer Immunology, Immunotherapy 51, 521-531, 2002 | 159 | 2002 |
| Heat shock proteins refine the danger theory SM Todryk, AA Melcher, AG Dalgleish, RG Vile Immunology 99 (3), 334, 2000 | 158 | 2000 |
| Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against … SM Keating, P Bejon, T Berthoud, JM Vuola, S Todryk, DP Webster, ... The Journal of Immunology 175 (9), 5675-5680, 2005 | 156 | 2005 |
| An intelligent decision support system for leukaemia diagnosis using microscopic blood images S Chin Neoh, W Srisukkham, L Zhang, S Todryk, B Greystoke, ... Scientific reports 5 (1), 14938, 2015 | 147 | 2015 |
| A synthetic peptide adhesion epitope as a novel antimicrobial agent CG Kelly, JS Younson, BY Hikmat, SM Todryk, M Czisch, PI Haris, ... Nature biotechnology 17 (1), 42-47, 1999 | 138 | 1999 |
| Intelligent leukaemia diagnosis with bare-bones PSO based feature optimization W Srisukkham, L Zhang, SC Neoh, S Todryk, CP Lim Applied soft computing 56, 405-419, 2017 | 132 | 2017 |
| Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial FM Thompson, DW Porter, SL Okitsu, N Westerfeld, D Vogel, S Todryk, ... PLoS One 3 (1), e1493, 2008 | 131 | 2008 |
| Heat shock protein peptides reactive in patients with Behcet's disease are uveitogenic in Lewis rats MR Stanford, E Kasp, R Whiston, A Hasan, S Todryk, T Shinnick, ... Clinical & Experimental Immunology 97 (2), 226-231, 1994 | 126 | 1994 |
Sarah C GilbertProfessor of Vaccinology, Pandemic Sciences Institute, Oxford UniversityAdresse e-mail validée de ndm.ox.ac.uk
